Fig. 3

Characteristic features of COVID-19-associated coagulopathy. The clinical and laboratory features of COVID-19-associated coagulopathy (CAC) partially overlap with sepsis-induced coagulopathy (SIC)/disseminated intravascular coagulation (DIC), hemophagocytic syndrome (HPS)/hemophagocytic lymphohistiocytosis (HLH), antiphospholipid syndrome (APS), and thrombotic microangiopathy (TMA); however, it does not perfectly match with any of these other coagulopathies